Hoàng Hường, whose real name is Hoàng Thị Hường, was born in 1987 and hails from Phú Thọ. The Hoàng Hường brand is renowned for its ventures such as Hoàng Hường Pharmaceutical Joint Stock Company, Hoàng Hường International Dentistry, and Hoàng Hường Joint Bone Supplement, among others.
Additionally, the businesswoman has been the face of Crilin Women Health’s Virgin Lily Supplement, a product launched by Thiên Dược Pharmaceutical Joint Stock Company. Notably, Hoàng Hường and Thiên Dược Pharmaceuticals share a close relationship. On November 20, 2024, Nguyễn Văn Đại, CEO of Thiên Dược Pharmaceuticals, formalized a strategic partnership with entrepreneur Hoàng Hường.
Thiên Dược Pharmaceutical Building
Shortly after, on December 27, 2024, Hoàng Hường shared a video on her personal page, which boasts 1.3 million followers, celebrating the inauguration of the Thiên Dược Pharmaceutical Building.
Thiên Dược Pharmaceutical Joint Stock Company, originally established as Thiên Dược Limited Liability Company on April 27, 2007, specializes in the production of pharmaceuticals, chemical drugs, and medicinal herbs. Its headquarters are located at Lot F3, N5 Road, Nam Tân Uyên Industrial Park, Tân Hiệp Ward, Ho Chi Minh City (formerly Khánh Bình Ward, Tân Uyên Town, Bình Dương Province).
According to the business registration update on July 3, 2019, Thiên Dược Pharmaceuticals has a charter capital of 50 billion VND, with three shareholders: Nguyễn Thị Ngọc Trâm contributing over 46.3 billion VND (92.625%), Nguyễn Như Trang contributing 1 million VND (0.002%), and Nguyễn Mạnh Hùng contributing nearly 3.7 billion VND (7.373%).
At that time, Nguyễn Thị Ngọc Trâm (born in 1947), a Pharmacist and Chemistry PhD, served as the Legal Representative, Chairwoman of the Board of Directors, and CEO. She is also the founder of Thiên Dược Pharmaceuticals.
On March 3, 2021, Nguyễn Đình Tuấn (born in 1990) succeeded Nguyễn Thị Ngọc Trâm as CEO and Legal Representative. Subsequently, on June 1, 2021, the company increased its charter capital from 50 billion VND to 75 billion VND, though the shareholder structure was not disclosed.
On June 2, 2023, Nguyễn Văn Đại (born in 1988) took over as CEO and Legal Representative, replacing Nguyễn Đình Tuấn. Six months later, on December 6, 2023, the company raised its charter capital to 100 billion VND, followed by another increase to nearly 152.6 billion VND on March 11, 2024.
As of December 8, 2024, Nguyễn Văn Đại remains the CEO and Legal Representative of the company.
In addition to his role at Thiên Dược Pharmaceuticals, Đại serves as the Director and Legal Representative of Tân Quang Plastic Joint Stock Company, established on August 5, 2022. The company specializes in the production of primary plastic and synthetic rubber, with an initial charter capital of 70 billion VND. Its shareholders include Sinh Thái Việt Nam Plastic Joint Stock Company (32 billion VND, 45.714%), Phạm Lan Anh (30 billion VND, 42.857%), and Đồng Văn Quang (8 billion VND, 11.429%).
Khánh Hân
